M K Proteins Limited (ISIN: INE964W01021) has announced significant changes to its board and upcoming annual general meeting (AGM) schedule. The company's board of directors, in a meeting held on August 23, 2025, made several key decisions that will shape its governance and shareholder engagement in the coming months.

New Independent Director Appointment

Mr. Deepak Khetarpal has been appointed as an Additional Director (Non-Executive, Independent) on the company's board. This appointment, effective from August 23, 2025, is subject to shareholder approval at the upcoming AGM. Mr. Khetarpal's term is set for five years, pending this approval.

Profile of the New Director

Mr. Khetarpal brings a wealth of experience to M K Proteins Limited:

• Qualified Cost and Works Accountant (CMA) from the Institute of Cost Accountants of India
• Expertise spanning Costing, Finance, Business Management, Accounting, and Income Tax
• Known for sharp analytical skills, strategic financial acumen, and result-oriented approach
• Currently holds no directorships in other listed entities
• Not related to any existing directors on the M K Proteins board

13th Annual General Meeting Details

The company has set the date for its 13th Annual General Meeting:

This virtual format aligns with the circulars issued by the Ministry of Corporate Affairs (MCA) and the Securities and Exchange Board of India (SEBI).

Book Closure and Important Dates

For the purpose of the AGM, M K Proteins has announced a book closure period:

• Book Closure Period: September 13, 2025 (Saturday) to September 19, 2025 (Friday)
• Both days are inclusive
• The Register of Members and Share Transfer Books will remain closed during this period

Additional Board Meeting Outcomes

The board meeting, which commenced at 4:30 PM and concluded at 5:30 PM on August 23, 2025, also approved:

1. The notice for the 13th Annual General Meeting
2. The Directors' Report along with annexures

Shareholders can expect to receive the AGM Notice and Annual Report for the year ended March 31, 2025, in due course.

This series of announcements demonstrates M K Proteins Limited's commitment to corporate governance and shareholder engagement. The appointment of Mr. Deepak Khetarpal as an Independent Director, subject to shareholder approval, is expected to bring valuable financial and management expertise to the company's board.

MK Proteins Limited, a leading manufacturer of vegetable refined oil, has reported robust financial results for the first quarter ended June 30, 2025, alongside significant changes in its auditing team.

Financial Performance

The company witnessed substantial growth in its Q1 FY2025-26 performance:

M.K. Proteins' revenue from operations doubled to ₹11,494.60 lacs in Q1 FY2025-26, compared to ₹5,733.30 lacs in the same quarter last year, marking a significant year-on-year growth of 100.49%. The company's net profit also saw a substantial increase, rising by 41.59% to ₹351.32 lacs from ₹248.13 lacs in the corresponding quarter of the previous fiscal year.

Auditor Changes

In a board meeting held on August 12, 2025, M.K. Proteins announced several changes to its auditing team:

1. Statutory Auditor Resignation: M/s. KRA & Co., Chartered Accountants (FRN: 020266N), the company's statutory auditors, have resigned effective August 12, 2025. The company stated that no concerns were raised by the outgoing auditors regarding their departure.

2. New Statutory Auditor Appointment: The board has approved the appointment of M/s. Subhash Sajal & Associates, Chartered Accountants (FRN: 018178N), as the new statutory auditors. They will fill the casual vacancy left by KRA & Co. and will hold office until the conclusion of the 13th Annual General Meeting. This appointment is subject to shareholder approval within three months.

3. Secretarial Auditor Appointment: M/s. J.P. Jagdev & Co., a peer-reviewed firm of practicing company secretaries, has been appointed as the secretarial auditors for a five-year term from FY2025-26 to FY2029-30. This appointment is subject to approval at the upcoming Annual General Meeting.

Company Operations

M.K. Proteins Limited continues to focus on its core business of manufacturing vegetable refined oil. The company reported no separate reportable segments, indicating a concentrated approach to its primary operations.

The unaudited financial results for Q1 FY2025-26 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting on August 12, 2025. These results are in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.